Taraseviciute Agne, Voelkel Norbert F
Pulmonary Hypertension Center, University of Colorado Health Science Center, Box C272, 4200 E. 9th Ave., Denver, Colorado 80262, USA.
Eur J Med Res. 2006 May 5;11(5):198-202.
Severe pulmonary hypertension (PH) is a rare disorder triggered by a variety of factors and disease conditions and characterized by a shared pathophysiology. Two decades ago it was widely held that "primary" (idiopathic) pulmonary hypertension (PPH) is a disease of young women. However, we noticed recently in the UCHSC Pulmonary Hypertension Center that women with severe PH are frequently postmenopausal and overweight or obese.
To determine whether severe PH is a disease not only of young women but also of postmenopausal women who are overweight or obese.
DESIGN, SETTING, AND PARTICIPANTS: The medical records of 541 postmenopausal female patients at the UCHSC Pulmonary Hypertension Center were reviewed. The patients were divided into two groups based on their diagnosis of either primary or secondary PH.
The medical records of postmenopausal women with severe PH were further reviewed for history of diabetes, systemic hypertension, and the use of anti-depressants, hormone replacement therapy, combination of anti-depressants and hormone replacement therapy, as well as anorexigens. Laboratory data such as elevated cholesterol, elevated uric acid, and elevated C-reactive protein (CRP) were recorded in these patients, as well as physical exam data to determine the body-mass index (BMI) of the patients.
56% of all pulmonary hypertensive women who were patients at the UCHSC Pulmonary Hypertension Center were postmenopausal. 39% of postmenopausal women with PPH and 48% with secondary severe PH were obese. In addition, postmenopausal obese women frequently had systemic hypertension and were on hormone replacement therapy as well as antidepressant medication.
Obesity, hormone replacement therapy and anti-depressant therapy may contribute to the development of severe PH in genetically predisposed women. Further investigation, in the form of a prospective, case-control study, is needed to determine whether these factors exert a causative effect in postmenopausal women.
重度肺动脉高压(PH)是一种由多种因素和疾病状况引发的罕见疾病,具有共同的病理生理学特征。二十年前,人们普遍认为“原发性”(特发性)肺动脉高压(PPH)是年轻女性的疾病。然而,我们最近在犹他大学健康科学中心肺动脉高压中心注意到,重度PH女性患者常为绝经后女性,且超重或肥胖。
确定重度PH是否不仅是年轻女性的疾病,也是超重或肥胖的绝经后女性的疾病。
设计、地点和参与者:回顾了犹他大学健康科学中心肺动脉高压中心541名绝经后女性患者的病历。根据原发性或继发性PH诊断将患者分为两组。
进一步回顾重度PH绝经后女性患者的病历,了解糖尿病史、系统性高血压史以及抗抑郁药、激素替代疗法、抗抑郁药与激素替代疗法联合使用情况,以及食欲抑制剂使用情况。记录这些患者的实验室数据,如胆固醇升高、尿酸升高和C反应蛋白(CRP)升高,以及体格检查数据以确定患者的体重指数(BMI)。
在犹他大学健康科学中心肺动脉高压中心就诊的所有肺动脉高压女性患者中,56%为绝经后女性。39%的绝经后PPH女性和48%的继发性重度PH女性肥胖。此外,绝经后肥胖女性常患有系统性高血压,且正在接受激素替代疗法和抗抑郁药物治疗。
肥胖、激素替代疗法和抗抑郁疗法可能在遗传易感性女性中促使重度PH的发生。需要进行前瞻性病例对照研究形式的进一步调查,以确定这些因素在绝经后女性中是否具有因果作用。